Literature DB >> 20418884

Disruption of antigenic variation is crucial for effective parasite vaccine.

Fernando D Rivero1, Alicia Saura, Cesar G Prucca, Pedro G Carranza, Alessandro Torri, Hugo D Lujan.   

Abstract

Giardia lamblia is a human intestinal pathogen. Like many protozoan microorganisms, Giardia undergoes antigenic variation, a mechanism assumed to allow parasites to evade the host's immune response, producing chronic and/or recurrent infections. Recently, we found that the mechanism controlling variant-specific surface protein (VSP) switching in Giardia involves components of the RNA interference machinery and that disruption of this pathway generates trophozoites simultaneously expressing many VSPs. Here we use these altered trophozoites to determine the role of antigenic variation in a gerbil model of giardiasis. Our results show that either primary infection with trophozoites simultaneously expressing many VSPs or immunization with purified VSPs from the transgenic cells protects gerbils from subsequent Giardia infections. These results constitute, to our knowledge, the first experimental evidence that antigenic variation is essential for parasite survival within hosts and that artificial disruption of this mechanism might be useful in generating vaccines against major pathogens that show similar behavior.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418884     DOI: 10.1038/nm.2141

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  58 in total

Review 1.  Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

Authors:  Jamie F S Mann; Reinaldo Acevedo; Judith Del Campo; Oliver Pérez; Valerie A Ferro
Journal:  Expert Rev Vaccines       Date:  2009-01       Impact factor: 5.217

2.  Electron microscopical investigation of surface alterations on Giardia lamblia trophozoites after exposure to a cytotoxic monoclonal antibody.

Authors:  A Hemphill; S Stäger; B Gottstein; N Müller
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

3.  Antigenic variation of Giardia lamblia in the feces of Mongolian gerbils.

Authors:  D M Moss; H M Mathews; G S Visvesvara; J W Dickerson; E M Walker
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

Review 4.  Mechanisms of Giardia lamblia differentiation into cysts.

Authors:  H D Luján; M R Mowatt; T E Nash
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

Review 5.  Drug resistance in Giardia intestinalis.

Authors:  J A Upcroft; P Upcroft; P F Boreham
Journal:  Int J Parasitol       Date:  1990-07       Impact factor: 3.981

6.  Variant surface antigens of Giardia lamblia are associated with the presence of a thick cell coat: thin section and label fracture immunocytochemistry survey.

Authors:  P F Pimenta; P P da Silva; T Nash
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum.

Authors:  D R Hill; J J Burge; R D Pearson
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  Carboxy-terminal sequence conservation among variant-specific surface proteins of Giardia lamblia.

Authors:  M R Mowatt; A Aggarwal; T E Nash
Journal:  Mol Biochem Parasitol       Date:  1991-12       Impact factor: 1.759

9.  Purification of a variant-specific surface protein of Giardia lamblia and characterization of its metal-binding properties.

Authors:  H D Luján; M R Mowatt; J J Wu; Y Lu; A Lees; M R Chance; T E Nash
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

10.  Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum.

Authors:  Christopher J Tonkin; Céline K Carret; Manoj T Duraisingh; Till S Voss; Stuart A Ralph; Mirja Hommel; Michael F Duffy; Liliana Mancio da Silva; Artur Scherf; Alasdair Ivens; Terence P Speed; James G Beeson; Alan F Cowman
Journal:  PLoS Biol       Date:  2009-04-14       Impact factor: 8.029

View more
  32 in total

1.  Calling all antigens.

Authors:  Kirk Deitsch
Journal:  Nat Med       Date:  2010-05       Impact factor: 53.440

2.  Identification of Conserved Candidate Vaccine Antigens in the Surface Proteome of Giardia lamblia.

Authors:  Barbara J Davids; Ching M Liu; Elaine M Hanson; Christine H Y Le; Jonathan Ang; Kurt Hanevik; Marvin Fischer; Matej Radunovic; Nina Langeland; Marcela Ferella; Staffan G Svärd; Majid Ghassemian; Yukiko Miyamoto; Lars Eckmann
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

3.  Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model.

Authors:  Gabriela Jenikova; Petr Hruz; Mattias K Andersson; Noa Tejman-Yarden; Patricia C D Ferreira; Yolanda S Andersen; Barbara J Davids; Frances D Gillin; Staffan G Svärd; Roy Curtiss; Lars Eckmann
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

Review 4.  Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.

Authors:  Wim G J Hol
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-16       Impact factor: 1.056

5.  The Critical Role of the Cytoskeleton in the Pathogenesis of Giardia.

Authors:  Christopher Nosala; Scott C Dawson
Journal:  Curr Clin Microbiol Rep       Date:  2015-10-08

Review 6.  Vaccines to combat the neglected tropical diseases.

Authors:  Jeffrey M Bethony; Rhea N Cole; Xiaoti Guo; Shaden Kamhawi; Marshall W Lightowlers; Alex Loukas; William Petri; Steven Reed; Jesus G Valenzuela; Peter J Hotez
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 7.  Chromatin modifications, epigenetics, and how protozoan parasites regulate their lives.

Authors:  Matthew M Croken; Sheila C Nardelli; Kami Kim
Journal:  Trends Parasitol       Date:  2012-04-03

8.  Cytokines, Antibodies, and Histopathological Profiles during Giardia Infection and Variant-Specific Surface Protein-Based Vaccination.

Authors:  Marianela C Serradell; Pablo R Gargantini; Alicia Saura; Sergio R Oms; Lucía L Rupil; Luciana Berod; Tim Sparwasser; Hugo D Luján
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

9.  Mucosal microbial parasites/symbionts in health and disease: an integrative overview.

Authors:  Robert P Hirt
Journal:  Parasitology       Date:  2019-08       Impact factor: 3.234

10.  Resistance to reinfection in mice as a vaccine model for giardiasis.

Authors:  Erqiu Li; Mingqiu Liu; Steven M Singer
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.